• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Comprehensive Overview of 4-(azetidin-3-yloxy)pyridine dihydrochloride (CAS No. 1251922-58-3)

4-(azetidin-3-yloxy)pyridine dihydrochloride (CAS No. 1251922-58-3) is a specialized chemical compound gaining attention in pharmaceutical and biochemical research. This compound, characterized by its unique azetidine and pyridine moieties, is widely explored for its potential applications in drug discovery and medicinal chemistry. Researchers are particularly interested in its role as a building block for synthesizing novel therapeutics targeting central nervous system (CNS) disorders and inflammatory diseases.

The molecular structure of 4-(azetidin-3-yloxy)pyridine dihydrochloride features a pyridine ring linked to an azetidine group via an ether bond. This configuration enhances its reactivity and bioavailability, making it a valuable intermediate in organic synthesis. Recent studies highlight its utility in developing small-molecule inhibitors and kinase modulators, aligning with the growing demand for precision medicine and targeted therapies.

In the context of current trends, 4-(azetidin-3-yloxy)pyridine dihydrochloride is often discussed alongside AI-driven drug discovery and high-throughput screening. With the rise of computational chemistry and machine learning in pharmaceutical R&D, this compound's structure-activity relationship (SAR) is being extensively modeled to predict its efficacy in drug candidates. Searches for "azetidine derivatives in drug design" or "pyridine-based therapeutics" frequently reference this compound, reflecting its relevance in modern research.

From a synthetic perspective, CAS No. 1251922-58-3 is prized for its scalable production and compatibility with green chemistry principles. Innovations in catalytic processes and solvent-free reactions have further optimized its synthesis, addressing the pharmaceutical industry's push for sustainable manufacturing. This aligns with popular queries like "eco-friendly synthesis of heterocycles" and "green chemistry in API development."

Safety and handling of 4-(azetidin-3-yloxy)pyridine dihydrochloride adhere to standard laboratory protocols. While not classified as hazardous, proper personal protective equipment (PPE) and ventilation are recommended during handling. Its stability under ambient conditions and solubility in polar solvents make it convenient for experimental use, as noted in searches for "handling azetidine compounds."

In summary, 4-(azetidin-3-yloxy)pyridine dihydrochloride (CAS No. 1251922-58-3) represents a versatile and promising compound in medicinal chemistry. Its applications span from CNS drug development to sustainable synthesis, resonating with contemporary scientific and industrial priorities. As research advances, this compound is poised to play a pivotal role in the next generation of therapeutic innovations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)